Your browser doesn't support javascript.
loading
Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study.
Lensing, Anthonie W A; Male, Christoph; Young, Guy; Kubitza, Dagmar; Kenet, Gili; Patricia Massicotte, M; Chan, Anthony; Molinari, Angelo C; Nowak-Goettl, Ulrike; Pap, Ákos F; Adalbo, Ivet; Smith, William T; Mason, Amy; Thelen, Kirstin; Berkowitz, Scott D; Crowther, Mark; Schmidt, Stephan; Price, Victoria; Prins, Martin H; Monagle, Paul.
Afiliación
  • Lensing AWA; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Male C; 2Department of Paediatrics, Medical University of Vienna, Wien, Austria.
  • Young G; 3Children's Hospital Los Angeles, Los Angeles, USA.
  • Kubitza D; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Kenet G; 4Sheba Medical Center, TelHashomer, Israel.
  • Patricia Massicotte M; 5University of Alberta, Edmonton, Canada.
  • Chan A; 6Department of Pediatrics, McMaster University, Hamilton, Canada.
  • Molinari AC; 7Giannina Gaslini Children's Hospital, Genoa, Italy.
  • Nowak-Goettl U; 8University Hospital Schleswig-Holstein, Kiel, Germany.
  • Pap ÁF; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Adalbo I; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Smith WT; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Mason A; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Thelen K; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Berkowitz SD; 1Bayer AG, Research and Development, Thrombosis and Hematology, Building 402, room 304, Aprather Weg 18a, 42113 Wuppertal, Germany.
  • Crowther M; 9Department of Medicine, Hematology and Thromboembolism McMaster University, Hamilton, ON Canada.
  • Schmidt S; 10Center for Pharmacometrics & Systems Pharmacology, Department of Pharmaceutics University of Florida, Orlando, FL USA.
  • Price V; 11Department of Pediatrics, Division of Pediatric Hematology-Oncology Dalhousie University, Halifax, Canada.
  • Prins MH; 12Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
  • Monagle P; Royal Children's Hospital, University of Melbourne, Murdoch Childrens Research Institute, Melbourne, Australia.
Thromb J ; 16: 34, 2018.
Article en En | MEDLINE | ID: mdl-30598642
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Thromb J Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Thromb J Año: 2018 Tipo del documento: Article País de afiliación: Alemania